These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease. Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway. Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914 [TBL] [Abstract][Full Text] [Related]
11. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation. Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804 [TBL] [Abstract][Full Text] [Related]
12. MiR-192-5p Ameliorates Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease by Targeting Ma L; Song H; Zhang CY; Hou D Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254634 [TBL] [Abstract][Full Text] [Related]
13. Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH. Tran M; Lee SM; Shin DJ; Wang L JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093267 [TBL] [Abstract][Full Text] [Related]
14. Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122/YY1/ACE2-MAS1 pathway. Liu H; He B; Hu W; Liu K; Dai Y; Zhang D; Wang H Biochem Pharmacol; 2021 Mar; 185():114420. PubMed ID: 33460628 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1. Zhang M; Tang Y; Tang E; Lu W Biochem Biophys Res Commun; 2020 Apr; 524(3):716-722. PubMed ID: 32035613 [TBL] [Abstract][Full Text] [Related]
16. miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease. Ali O; Darwish HA; Eldeib KM; Abdel Azim SA Oxid Med Cell Longev; 2018; 2018():8515343. PubMed ID: 30402207 [TBL] [Abstract][Full Text] [Related]
17. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis. Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132 [TBL] [Abstract][Full Text] [Related]
18. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1. Ao R; Wang Y; Tong J; Wang BF Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease. Xu M; Zheng XM; Jiang F; Qiu WQ J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055 [TBL] [Abstract][Full Text] [Related]
20. MiR-22 modulates the expression of lipogenesis-related genes and promotes hepatic steatosis in vitro. Yang Z; Qin W; Huo J; Zhuo Q; Wang J; Wang L FEBS Open Bio; 2021 Jan; 11(1):322-332. PubMed ID: 33159388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]